Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care

Older patients with newly diagnosed acute myeloid leukemia (AML) in the phase 3 AZA-AML-001 study were evaluated at entry for cytogenetic abnormalities, and a subgroup of patients was assessed for gene mutations. Patients received azacitidine 75 mg/m2/day x7 days (n = 240) or conventional care regim...

Ամբողջական նկարագրություն

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ:	Döhner, H, Dolnik, A, Tang, L, Seymour, JF, Minden, MD, Stone, RM, Del Castillo, TB, Al-Ali, HK, Santini, V, Vyas, P, Beach, CL, Macbeth, KJ, Skikne, BS, Songer, S, Tu, N, Bullinger, L, Dombret, H
Ձևաչափ:	Journal article
Լեզու:	English
Հրապարակվել է:	Springer Nature 2018

Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care

Նմանատիպ նյութեր